C12Y 114/99009
Steroid 17-alpha-monooxygenase , i.e. cytochrome-p450-steroid-17-alpha-hydroxylase
Official title: Steroid 17-alpha-monooxygenase (1.14.99.9), i.e. cytochrome-P450-steroid-17-alpha-hydroxylase
C12Y114/99009 (Steroid 17-alpha-monooxygenase , i.e. cytochrome-p450-steroid-17-alpha-hydroxylase) appears on 10 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 5
- Assignees
- 9
- Inventors
- 22
- Latest grant
- 15 Mar 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Microbial production of natural sweeteners, diterpenoid steviol glycosides15 Mar 2016US 9,284,570 B2Massachusetts Institute of Technology
- Yeast strains autonomously producing steroids12 Jul 2011US 7,977,065 B2Aventis Pharma S. A.
- Yeast strains autonomously producing steroids2 Mar 2010US 7,670,829 B2Aventis Pharma S. A.
- Process for oxidation of steroids and genetically engineered cells used therein14 Oct 2003US 6,632,633 B1Aventis Pharma S. A.
- Process for oxidation of steroids and genetically engineered cells used therein9 Jan 2001US 6,171,836 B2Hoechst Marion Roussel, Inc.
- Microbial production of natural sweeteners, diterpenoid steviol glycosides28 Jun 2012US 2012/0164678 A1Massachusetts Institute of Technology
- Yeast strains autonomously producing steroids6 May 2010US 2010/0112634 A1Aventis Pharma S. A.
- Yeast strains autonomously producing steroids15 Jul 2004US 2004/0137556 A1Aventis Pharma S. A.
- Process for oxidation of steroids and genetically engineered cells used therein8 Apr 2004US 2004/0067579 A1Aventis Pharma S.A.
- Process for oxidation of steroids and genetically engineered cells used therein12 Jun 2003US 2003/0108982 A1Aventis Pharma S.A.
Most cited
By later US patents
- Microbial production of natural sweeteners, diterpenoid steviol glycosides26US 9,284,570 B2Massachusetts Institute of Technology · 2016
- Methods and compositions for the expression of biologically active eukaryotic cytochrome P45OS in bacteria23US 5,240,831 ABoard of Regents, The University of Texas · 1993
- Yeast strains autonomously producing steroids13US 7,670,829 B2Aventis Pharma S. A. · 2010
- Transformed yeasts having steroid-hydroxylase activity and process for hydroxylation of steroids using the said transformed yeasts9US 5,137,822 ADirector-General of Agency of Industrial Science & Technology an organ of The Ministry of Industrial Trade and Industry of Japan · 1992
- Methods and compositions for the expression of biologically active fusion proteins comprising a eukaryotic cytochrome P450 fused to a reductase in bacteria6US 5,420,027 ABoard of Regents, The University of Texas System · 1995